Adjuvant IO Therapy in Early-Stage NSCLC: The IMpower010 and PEARLS Trials
Expert perspectives on use of immunotherapy in the adjuvant setting of early-stage NSCLC in light of data from IMpower010 and PEARLS.
Adjuvant Osimertinib in Early-Stage NSCLC: The ADAURA Trial
Advances in Testing and Targeted Therapy for NSCLC: Translating Evidence to Clinical Practice
Selecting Appropriate Adjuvant Chemotherapy for Early-Stage NSCLC
Shared insight on the role and selection of adjuvant chemotherapy for patients with early-stage non–small cell lung cancer.
Treatment for Early-Stage NSCLC: Resection and Adjuvant Radiation Therapy
Shifting focus to early-stage NSCLC, expert panelists define the role of resection and consider when it is appropriate to utilize adjuvant radiation therapy.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
2 Clarke Drive Cranbury, NJ 08512